These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 26274041

  • 1. Fatty acid amide hydrolase inhibitor URB597 prevented tolerance and cognitive deficits induced by chronic morphine administration in rats.
    Hasanein P, Ghafari-Vahed M.
    Behav Pharmacol; 2016 Feb; 27(1):37-43. PubMed ID: 26274041
    [Abstract] [Full Text] [Related]

  • 2. Reducing endocannabinoid metabolism with the fatty acid amide hydrolase inhibitor, URB597, fails to modify reinstatement of morphine-induced conditioned floor preference and naloxone-precipitated morphine withdrawal-induced conditioned floor avoidance.
    McCallum AL, Limebeer CL, Parker LA.
    Pharmacol Biochem Behav; 2010 Oct; 96(4):496-500. PubMed ID: 20643159
    [Abstract] [Full Text] [Related]

  • 3. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats.
    Hasanein P, Teimuri Far M.
    Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415
    [Abstract] [Full Text] [Related]

  • 4. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
    Hasanein P, Shahidi S, Komaki A, Mirazi N.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):132-5. PubMed ID: 18593578
    [Abstract] [Full Text] [Related]

  • 5. Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms.
    Shahidi S, Hasanein P.
    Brain Res Bull; 2011 Aug 10; 86(1-2):118-22. PubMed ID: 21763761
    [Abstract] [Full Text] [Related]

  • 6. Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit.
    Slivicki RA, Saberi SA, Iyer V, Vemuri VK, Makriyannis A, Hohmann AG.
    J Pharmacol Exp Ther; 2018 Dec 10; 367(3):551-563. PubMed ID: 30275151
    [Abstract] [Full Text] [Related]

  • 7. URB597, an inhibitor of fatty acid amide hydrolase, reduces hyperalgesia in diabetic rats.
    Hasanein P, Parviz M, Keshavarz M, Roohbakhsh A.
    Can J Physiol Pharmacol; 2009 Jun 10; 87(6):432-9. PubMed ID: 19526037
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female rats.
    Hlavacova N, Chmelova M, Danevova V, Csanova A, Jezova D.
    Endocr Regul; 2015 Jul 10; 49(3):131-6. PubMed ID: 26238495
    [Abstract] [Full Text] [Related]

  • 9. The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues.
    Clapper JR, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    Pharmacol Res; 2006 Nov 10; 54(5):341-4. PubMed ID: 16935521
    [Abstract] [Full Text] [Related]

  • 10. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D.
    J Pharmacol Exp Ther; 2007 Jul 10; 322(1):236-42. PubMed ID: 17412883
    [Abstract] [Full Text] [Related]

  • 11. Pregabalin role in inhibition of morphine analgesic tolerance and physical dependency in rats.
    Hasanein P, Shakeri S.
    Eur J Pharmacol; 2014 Nov 05; 742():113-7. PubMed ID: 25220244
    [Abstract] [Full Text] [Related]

  • 12. Long-term administration of fatty acid amide hydrolase inhibitor (URB597) to rats with spontaneous hypertension disturbs liver redox balance and phospholipid metabolism.
    Biernacki M, Ambrożewicz E, Gęgotek A, Toczek M, Skrzydlewska E.
    Adv Med Sci; 2019 Mar 05; 64(1):15-23. PubMed ID: 30243113
    [Abstract] [Full Text] [Related]

  • 13. Effects of voluntary and treadmill exercise on spontaneous withdrawal signs, cognitive deficits and alterations in apoptosis-associated proteins in morphine-dependent rats.
    Mokhtari-Zaer A, Ghodrati-Jaldbakhan S, Vafaei AA, Miladi-Gorji H, Akhavan MM, Bandegi AR, Rashidy-Pour A.
    Behav Brain Res; 2014 Sep 01; 271():160-70. PubMed ID: 24906198
    [Abstract] [Full Text] [Related]

  • 14. Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats.
    Pędzińska-Betiuk A, Weresa J, Toczek M, Baranowska-Kuczko M, Kasacka I, Harasim-Symbor E, Malinowska B.
    Br J Pharmacol; 2017 Jul 01; 174(13):2114-2129. PubMed ID: 28437860
    [Abstract] [Full Text] [Related]

  • 15. Fatty acid amide hydrolase inhibitor (URB597) as a regulator of myocardial lipid metabolism in spontaneously hypertensive rats.
    Harasim-Symbor E, Polak A, Pędzińska-Betiuk A, Weresa J, Malinowska B, Lewandowska A, Kasacka I, Chabowski A.
    Chem Phys Lipids; 2019 Jan 01; 218():141-148. PubMed ID: 30578756
    [Abstract] [Full Text] [Related]

  • 16. The potency of the fatty acid amide hydrolase inhibitor URB597 is dependent upon the assay pH.
    Paylor B, Holt S, Fowler CJ.
    Pharmacol Res; 2006 Dec 01; 54(6):481-5. PubMed ID: 16997568
    [Abstract] [Full Text] [Related]

  • 17. Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease.
    Johnston TH, Huot P, Fox SH, Wakefield JD, Sykes KA, Bartolini WP, Milne GT, Pearson JP, Brotchie JM.
    J Pharmacol Exp Ther; 2011 Feb 01; 336(2):423-30. PubMed ID: 20966038
    [Abstract] [Full Text] [Related]

  • 18. The effects of fatty acid amide hydrolase inhibitors on maintenance of cocaine and food self-administration and on reinstatement of cocaine-seeking and food-taking behavior in rats.
    Adamczyk P, McCreary AC, Przegalinski E, Mierzejewski P, Bienkowski P, Filip M.
    J Physiol Pharmacol; 2009 Sep 01; 60(3):119-25. PubMed ID: 19826190
    [Abstract] [Full Text] [Related]

  • 19. Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid-induced damage to hippocampal neurons: Dependence on the degree of injury.
    Mikheeva IB, Shubina L, Matveeva N, Pavlik LL, Kitchigina VF.
    Epilepsy Res; 2017 Nov 01; 137():84-94. PubMed ID: 28963903
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of fatty acid amide hydrolase (FAAH) reduces spinal nociceptive responses and expression of spinal long-term potentiation (LTP).
    Eriksen GS, Jacobsen LM, Mahmood A, Pedersen LM, Gjerstad J.
    Brain Res Bull; 2012 Feb 10; 87(2-3):234-7. PubMed ID: 22133920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.